This course is part of PrimaryCareNow: Live on July 22, 2026.
Generic Placeholder Website Image

Activity content starts in:

Industry Webcast

Learn About a Nonhormonal FDA-Approved Treatment for Moderate to Severe Vasomotor Symptoms Due to Menopause.Industry Webcast Sponsored by Astellas Pharma US, Inc.; Not for CME/CE Credit

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 7/22/2026

Expiration Date: 7/22/2026

Topics

Faculty

Faculty

Supporters and Partners

Industry Sponsor

Astellas Pharma US, Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Learn About a Nonhormonal FDA-Approved Treatment for Moderate to Severe Vasomotor Symptoms Due to Menopause.

Register